ESR1Real World Assessment Prevalence Study
ESR1Real World Assessment Prevalence Study
Not yet recruiting · NCT07817212 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ESR1Real World Assessment Prevalence Study | HR+/HER2- aBC Undergoing 1L Treatment With CDK4/6i (Palbociclib, Abemaciclib or Ribociclib) and AI (Anastrozole or Letrozole) | Not yet recruiting | Not applicable | 2026-09-14 | NCT07817212 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
21 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.